PepGen Statistics
Total Valuation
PepGen has a market cap or net worth of $390.83 million. The enterprise value is $259.38 million.
Important Dates
The last earnings date was Wednesday, March 4, 2026, after market close.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PepGen has 68.75 million shares outstanding. The number of shares has increased by 33.69% in one year.
| Current Share Class | 68.75M |
| Shares Outstanding | 68.75M |
| Shares Change (YoY) | +33.69% |
| Shares Change (QoQ) | +100.19% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 51.03% |
| Float | 40.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.26 |
| P/TBV Ratio | 2.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.94, with a Debt / Equity ratio of 0.12.
| Current Ratio | 11.94 |
| Quick Ratio | 11.74 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.39% and return on invested capital (ROIC) is -38.78%.
| Return on Equity (ROE) | -67.39% |
| Return on Assets (ROA) | -36.03% |
| Return on Invested Capital (ROIC) | -38.78% |
| Return on Capital Employed (ROCE) | -58.05% |
| Weighted Average Cost of Capital (WACC) | 13.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.57M |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PepGen has paid $49,000 in taxes.
| Income Tax | 49,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +115.75% in the last 52 weeks. The beta is 1.87, so PepGen's price volatility has been higher than the market average.
| Beta (5Y) | 1.87 |
| 52-Week Price Change | +115.75% |
| 50-Day Moving Average | 5.89 |
| 200-Day Moving Average | 3.67 |
| Relative Strength Index (RSI) | 46.17 |
| Average Volume (20 Days) | 717,830 |
Short Selling Information
The latest short interest is 2.85 million, so 4.15% of the outstanding shares have been sold short.
| Short Interest | 2.85M |
| Short Previous Month | 2.78M |
| Short % of Shares Out | 4.15% |
| Short % of Float | 7.10% |
| Short Ratio (days to cover) | 3.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -93.61M |
| Pretax Income | -89.61M |
| Net Income | -89.66M |
| EBITDA | -92.22M |
| EBIT | -93.61M |
| Earnings Per Share (EPS) | -$2.12 |
Full Income Statement Balance Sheet
The company has $148.46 million in cash and $17.00 million in debt, with a net cash position of $131.45 million or $1.91 per share.
| Cash & Cash Equivalents | 148.46M |
| Total Debt | 17.00M |
| Net Cash | 131.45M |
| Net Cash Per Share | $1.91 |
| Equity (Book Value) | 147.44M |
| Book Value Per Share | 4.52 |
| Working Capital | 138.32M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$81.64 million and capital expenditures -$264,000, giving a free cash flow of -$81.90 million.
| Operating Cash Flow | -81.64M |
| Capital Expenditures | -264,000 |
| Free Cash Flow | -81.90M |
| FCF Per Share | -$1.19 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PepGen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.68% |
| Shareholder Yield | -33.68% |
| Earnings Yield | -22.94% |
| FCF Yield | -20.95% |
Analyst Forecast
The average price target for PepGen is $11.67, which is 105.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.67 |
| Price Target Difference | 105.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |